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Abstract
Epidermal growth factor (EGF) is a potent mitogen in many cell types including pancreatic cells. Recent studies show that
the effects of some growth factors on growth and cell migration are mediated by tyrosine phosphorylation of the cytosolic
tyrosine kinase p125 focal adhesion kinase (p125FAK) and the cytoskeletal protein, paxillin. The aim of the present study was
to determine whether EGF activates this pathway in rat pancreatic acini and causes tyrosine phosphorylation of each of these
proteins, and to examine the intracellular pathways involved. Treatment of pancreatic acini with EGF induced a rapid,
concentration-dependent increase in p125FAK and paxillin tyrosine phosphorylation. Depletion of the intracellular calcium
pool or inhibition of PKC activation had no effect on the response to EGF. However, inhibition of the phosphatidylinositol
3-kinase (PI3-kinase) or inactivation of p21rho inhibited EGF-stimulated phosphorylation of p125FAK and paxillin by more
than 70%. Finally, cytochalasin D, a selective disrupter of the actin filament network, completely inhibited EGF-stimulated
tyrosine phosphorylation of both proteins. All these treatments did not modify EGF receptor autophosphorylation in
response to EGF. These results identify p125FAK and paxillin as components of the intracellular pathways stimulated after
EGF receptor occupation in rat pancreatic acini. Activation of this cascade requires activation of PI3-kinase and
participation of p21rho, but not PKC activation and calcium mobilization. ß 1999 Elsevier Science B.V. All rights reserved.
Keywords: Epidermal growth factor; p125FAK ; Paxillin; Tyrosine kinase; Pancreatic acini ; p21rho
1. Introduction
Numerous studies have demonstrated that epider-
mal growth factor (EGF) may be important in the
regulation of growth of both normal pancreatic aci-
nar cells [1^3] and pancreatic ductal cells [4] as well
as an important growth factor for pancreatic cancer
[5,6]. The presence of EGF and its receptor has been
shown to correlate with large tumor size, advanced
clinical stage and decreased survival in patients with
pancreatic cancer [6,7].
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Recent studies demonstrate that one particularly
important intracellular signaling pathway used by
growth factors [8^12], in addition to bioactive lipids
[13], oncogenes [14], integrins [15] and some neuro-
peptides [16^18] is tyrosine phosphorylation of the
cytosolic tyrosine kinase, p125 focal adhesion kinase
(p125FAK) and the cytoskeletal docking protein, pax-
illin. Two recent studies in other tissues [19,20] report
that EGF can also stimulate tyrosine phosphoryla-
tion of p125FAK and paxillin, suggesting it could be
an important signaling cascade for the EGF receptor
in pancreatic acinar cells as well as these other tis-
sues.
EGF has been shown in pancreatic acinar cells to
alter phospholipase C (PLC) activity causing changes
in both inositol phosphate levels [21^23] and cyto-
solic calcium levels [24]. With some stimulants of
tyrosine phosphorylation of p125FAK and paxillin,
PLC activation is important for the tyrosine phos-
phorylation to occur [18,25^27], as well as the integ-
rity of the actin cytoskeleton [8,11,13,26,27], the par-
ticipation of phosphatidylinositol 3-kinase (PI3-
kinase) [19] and the participation of the small
GTP-binding protein, p21rho [27^29]. It is unknown
whether alterations in these intracellular pathways
might be involved in EGF’s ability to cause tyrosine
phosphorylation in rat pancreatic acini. Therefore,
the purpose of the present study was determine
whether activation of the pancreatic acinar EGF re-
ceptor results in increased tyrosine phosphorylation
of p125FAK and paxillin, and to determine whether
PLC activation or the participation of the actin cy-
toskeleton, PI3-kinase or the small GTP-binding pro-
tein, p21rho, are involved in this stimulation.
2. Materials and methods
2.1. Materials
Male Sprague^Dawley rats (150^200 g) were ob-
tained from the Small Animals Section, Veterinary
Resources Branch, NIH, Bethesda, MD or from
the Animal Farm, Faculty of Veterinary, UEX,
Spain; puri¢ed collagenase (type CLSPA) from Wor-
thington Biochemicals, Freehold, NJ; phosphate-
bu¡ered saline (PBS), pH 7.4, from Bio£uids, Rock-
ville, MD; anti-focal adhesion kinase (p125FAK)
monoclonal antibody, anti-paxillin monoclonal anti-
body and anti-phosphotyrosine monoclonal antibody
(PY20) from Transduction Laboratories, Lexington,
KY; recombinant protein A-agarose and anti-EGF
receptor polyclonal antibody from Upstate Biotech-
nology, Lake Placid, NY; epidermal growth factor
(EGF), GF109203X, thapsigargin, wortmannin,
LY294002 and deoxycholic acid from Calbiochem,
La Jolla, CA; soybean trypsin inhibitor (SBTI), di-
methyl sulfoxide (DMSO) and Triton X-100 from
Sigma, St. Louis, MO; phenylmethanesulfonyl £uo-
ride (PMSF) from Fluka, Ronkonkoma, MY; BME
amino acids and BME vitamin solution from Gibco
Laboratories, Grand Island, NY; bovine serum al-
bumin (BSA) fraction V from Miles, Kankakee, IL;
aprotinin, leupeptin and 4-[2-hydroxyethyl]-1-pipera-
zine ethanesulfonic acid (Hepes) from Boehringer
Mannheim, Indianapolis, IN; Clostridium botulinum
C3 transferase (C3 transferase) from List Biological
Laboratories, Campbell, CA; rabbit anti-mouse IgG
and anti-mouse IgG^horseradish peroxidase conju-
gate from Pierce, Rockford, IL; sodium dodecyl sul-
fate (SDS), 2-mercaptoethanol, protein assay dye
reagent, Tris/glycine/SDS bu¡er (10-times concen-
trated) and Tris/glycine bu¡er (10-times concen-
trated) from Bio-Rad, Richmond, CA; Hyper¢lm
ECL, enhanced chemiluminescence detection re-
agents, from Amersham, Arlington Heights, IL;




Dispersed rat pancreatic acini were prepared ac-
cording to the modi¢cations [30] of the procedure
published previously [31]. Unless otherwise stated,
the standard incubation solution contained (mM):
Hepes (25.5) (pH 7.4); NaCl (98); KCl (6);
NaH2PO4 (2.5); sodium pyruvate (5); sodium fuma-
rate (5); sodium glutamate (5); glucose (11.5); CaCl2
(0.5); MgCl2 (1); glutamine (2); albumin 1% (w/v);
trypsin inhibitor 1% (w/v); vitamin mixture 1% (v/v);
amino acid mixture 1% (w/v). The incubation solu-
tion was equilibrated with 100% O2 and all incuba-
tions were performed with 100% O2 as the gas phase.
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2.2.2. Immunoprecipitation
Dispersed pancreatic acini from one rat pancreas
were preincubated with standard incubation solution
without or with di¡erent inhibitors for 3 h at 37‡C.
Aliquots (1 ml) were then incubated at 37‡C with
EGF at the concentrations and times indicated. Acini
were then separated by centrifugation, washed with
PBS with 0.2 mM Na3VO4 at 4‡C, centrifuged and
sonicated for 5 s at 4‡C in 1 ml of a solution con-
taining 50 mM Tris^HCl (pH 7.5), 150 mM NaCl,
1% (v/v) Triton X-100, 1% (w/v) deoxycholate, 0.1%
(w/v) NaN3, 1 mM EGTA, 0.4 mM EDTA, 2.5 Wg/
ml aprotinin, 2.5 Wg/ml leupeptin, 1 mM PMSF and
0.2 mM Na3VO4. Lysates were centrifuged at
10 000Ug for 15 min. Protein concentration was
measured by the Bio-Rad protein assay reagent and
the volume adjusted such that 1-ml aliquots of acinar
lysates containing the same amount of protein (500
Wg/ml) were incubated with 4 Wg of anti-phosphoty-
rosine monoclonal antibody (PY20), 4 Wg of goat
anti-mouse IgG and 30 Wl of protein A-agarose, or
with 12 Wg of anti-EGF receptor polyclonal antibody
and 30 Wl of protein A-agarose, overnight at 4‡C.
The immunoprecipitates were washed three times
with PBS and further analyzed by SDS^polyacryla-




fractionated by SDS^PAGE with a NOVEX system
using 10% polyacrylamide gels. Proteins with molec-
ular mass higher than 60 kDa were transferred to
0.45-Wm pore size nitrocellulose membranes. Mem-
branes were blocked overnight at 4‡C using BLOT-
TO (5% non-fat dried milk in a solution containing
50 mM Tris^HCl (pH 8.0), 2 mM CaCl2, 80 mM
NaCl, 0.05% (v/v) Tween-20, 0.02% (w/v) NaN3)
and incubated for 5 h at 25‡C with 1 Wg/ml anti-
phosphotyrosine monoclonal antibody (PY20) or
for 2 h with 0.25 Wg/ml anti-p125FAK monoclonal
antibody or 0.025 Wg/ml anti-paxillin monoclonal
antibody. After incubation with the primary anti-
body, membranes were washed twice for 10 min
with BLOTTO and incubated for 1 h at 25‡C with
anti-mouse IgG^horseradish peroxidase conjugate.
The membrane were ¢nally washed twice for 10 min
with BLOTTO and twice for 10 min with washing
solution (50 mM Tris^HCl (pH 8.0), 2 mM CaCl2,
80 mM NaCl, 0.05% (v/v) Tween-20), incubated with
enhanced chemiluminescence detection reagents
(ECL) for 60 s and exposed to Hyper¢lm ECL.
The density of bands on the ¢lm were measured us-
ing a scanning densitometer (Molecular Dynamics,
Sunnyvale, CA).
2.2.4. Statistical methods
Comparisons were made using the unpaired Stu-
dent’s t-test. Values with P6 0.05 were considered
signi¢cant. Results are expressed as mean þ S.E.M.
3. Results
Treatment of pancreatic acini with 10 nM epider-
mal growth factor (EGF) causes a rapid increase in
the tyrosine phosphorylation of at least four phos-
photyrosine-containing bands with molecular masses
greater than 60 kDa, which was the range examined
in the present study. These bands correspond to Mr
170 000^175 000, 125 000^135 000, 100 000^105 000
and 70 000^80 000 and will be referred to as p175,
p130, p105 and p75 (Fig. 1) for each of the proteins
tyrosine-phosphorylated. In some experiments a
90 000^95 000 kDa band was seen (Fig. 1); however,
this was not a consistent result. The increase in ty-
rosine phosphorylation after EGF addition reached a
maximum at either 1 or 2.5 min with the di¡erent
proteins and decreased rapidly after 2.5 min (Fig. 1,
lanes 2^5).
The cellular e¡ects of EGF are mediated through
the 170 kDa EGF receptor, that possess intrinsic
tyrosine kinase activity [32]. The binding of EGF
to its receptor results in phosphorylation of tyrosine
residues via an autophosphorylation mechanism
[32,33]. To determine whether the p175 phosphoty-
rosine-containing band stimulated by EGF, is the
EGF receptor (EGFR), pancreatic acini were treated
with EGF (10 nM) for 2.5 min and then lysed.
Lysates of EGF-treated pancreatic acini were immu-
noprecipitated with anti-EGF receptor antibody fol-
lowed by immunoblotting with anti-phosphotyrosine
mAb (PY20). As shown in Fig. 2 (lane 2), EGF
caused a striking increase in the tyrosine phospho-
rylation of the pancreatic acinar EGF receptor which
migrated as a broad band of Mr 170 000^175 000. No
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other phosphotyrosine-containing bands were ob-
served in anti-EGFR immunocomplexes. The band
observed after immunoprecipitation with anti-
EGFR antibody exactly comigrated with the p175
phosphotyrosine-containing band observed by anti-
phosphotyrosine immunoblotting of anti-phospho-
tyrosine immunoprecipitates (Fig. 2, compare lanes
2 and 3). Furthermore, lysates of EGF-treated pan-
creatic acini, from which EGFR had previously been
removed by incubation with anti-EGFR antibody,
showed no increase in anti-phosphotyrosine immu-
noreactivity in the p175 band (Fig. 2, lane 4).
In previous studies [17,27], rat pancreatic acini
have been shown to posses both the 125 kDa cyto-
solic protein focal adhesion kinase (p125FAK), and
the 72 kDa cytoskeletal-associated protein, paxillin,
and their tyrosine phosphorylation to be increased
by cholecystokinin or the phorbol ester, TPA. To
determine whether EGF could also stimulate tyrosine
phosphorylation of these two proteins and whether
they were components of the p130 and p75 phospho-
tyrosine-containing bands tyrosine-phosphorylated
by EGF, the immunoprecipitates with anti-phospho-
tyrosine mAb were examined using speci¢c anti-
p125FAK and anti-paxillin mAbs (Fig. 3, top panel).
The addition of 10 nM EGF caused a 2.3 þ 0.3-fold
increase and a 1.9 þ 0.3-fold increase in p125FAK and
paxillin tyrosine phosphorylation, respectively, which
reached a maximum by 1 min (Fig. 3, top panel)
followed by decrease after 2.5 min (Fig. 3, bottom
panel). The e¡ect of EGF on p125FAK and paxillin
tyrosine phosphorylation was concentration-depend-
ent (Fig. 4, top panel). At a 10 pM concentration
EGF caused a 20% increase in tyrosine phosphoryl-
ation, a half-maximal e¡ect occurred at 0.1 nM and
a maximal e¡ect occurred at 10 nM for both
Fig. 2. EGF stimulation of EGF receptor tyrosine phosphoryla-
tion. Acinar pancreatic cells were incubated either in the ab-
sence (lane 1) or in the presence of 10 nM EGF (lanes 2^4) for
2.5 min at 37‡C and then lysed. Lanes 1 and 2, acinar cells ly-
sates were immunoprecipitate overnight with EGF receptor Ab;
lane 3, lysates were immunoprecipitate with PY20; lane 4, cells
lysates were immunoprecipitated overnight with anti-EGF re-
ceptor Ab and, following removal of anti-EGF receptor immu-
noprecipitates, the lysates were immunoprecipitate with anti-
phosphotyrosine Ab. Immunoprecipitates were analyzed by
Western blotting with anti-phosphotyrosine mAb as described
in Section 2. The position of the EGF receptor is indicated on
the right. The positions of molecular mass markers are shown
on the left. These results are representative of at least four ex-
periments in duplicate.
Fig. 1. Time course of epidermal growth factor (EGF) stimula-
tion of tyrosine phosphorylation in rat pancreatic acini. Rat
pancreatic acini were incubated with 10 nM of EGF for the in-
dicated times. Acini were then lysed and immunoprecipitate
with anti-phosphotyrosine monoclonal Ab (PY20). Immunopre-
cipitates were analyzed by SDS^PAGE followed by transfer of
proteins of molecular masses s 60 kDa to nitrocellulose mem-
brane and anti-phosphotyrosine immunoblotting, as described
in Section 2. Bands were visualized using ECL and quanti¢ca-
tion of phosphorylation was performed by scanning densitome-
try. The autoradiogram shows the tyrosine phosphorylation re-
sults from a representative experiment with no addition or with
EGF (10 nM) at various times. The position of the phosphoty-
rosine-containing bands are indicated on the right. The position
of molecular mass markers are shown on the left. These results
are representative of at least seven experiments in duplicate.
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p125FAK and paxillin tyrosine phosphorylation (Fig.
4, bottom panel).
After EGF binds to the EGFR, several cytoplas-
mic e¡ector proteins associate with speci¢c phospho-
tyrosine residues on the EGFR, initiating di¡erent
signal transduction pathways [32,33]. One of these
cytoplasmic e¡ector proteins which bind to the
EGFR and becomes activated is phospholipase CQ
(PLCQ) [34]. Activation of PLCQ results in increases
in intracellular calcium levels and activation of pro-
tein kinase C (PKC) [34]. To determine whether PKC
activation might be involved in mediating the EGF-
stimulated changes in p125FAK and paxillin tyrosine
phosphorylation, we examined the e¡ect of a PKC
inhibitor, GF109203X [35], on EGF stimulation of
p125FAK and paxillin tyrosine phosphorylation. Pre-
viously, we have shown that pretreatment of pancre-
atic acini with 5 WM of GF109203X for 30 min
caused complete inhibition of tyrosine phosphoryla-
tion of p125FAK and paxillin induced by activation of
PKC with TPA [27]. However, GF109203X pretreat-
ment did not modify EGF-stimulated p125FAK and
paxillin tyrosine phosphorylation (Fig. 5A, lanes 3
and 4) or basal tyrosine phosphorylation in control
cells in the absence of EGF (Fig. 5A, lanes 1 and 2).
Moreover, EGF stimulation of EGFR tyrosine phos-
phorylation was not altered by pretreatment with the
PKC inhibitor (Fig. 5A, lanes 3 and 4). To examine
the possible contribution of EGF-induced changes in
[Ca2]i to its ability to cause tyrosine phosphoryla-
tion of p125FAK and paxillin, the e¡ect of thapsigar-
Fig. 3. Time course of EGF stimulation of p125FAK and paxil-
lin tyrosine phosphorylation in rat pancreatic acini. Rat pancre-
atic acini were treated with 10 nM EGF at the indicated times
and then lysed. Whole-cell lysates were immunoprecipitated
with anti-phosphotyrosine mAb (PY20). Immunoprecipitate
were analyzed by SDS^PAGE followed by transfer of proteins
of molecular masses s 60 kDa to nitrocellulose membrane and
anti-p125FAK and anti-paxillin immunoblotting as described in
Section 2. Bands were visualized using ECL and quanti¢cation
of phosphorylation was performed by scanning densitometry.
The top panel shows p125FAK and paxillin tyrosine phosphoryl-
ation results from a representative experiment with EGF
(10 nM) at the indicated times for both proteins. These results
are representative of another six others. The bottom panel
shows the quanti¢cation of p125FAK and paxillin tyrosine phos-
phorylation. Values are the mean þ S.E.M. (n = 7) expressed as
-fold increase over the pretreatment level (experimental/control).
Fig. 4. Concentration dependence of EGF stimulation of
p125FAK and paxillin tyrosine phosphorylation in rat pancreatic
acini. Rat pancreatic acini were treated with the indicated con-
centrations of EGF for 2.5 min at 37‡C and p125FAK and pax-
illin tyrosine phosphorylation determined as described in Fig. 3.
Results shown in the top panel are from a typical experiment
representative of six others in duplicate. The bottom panel
shows the quanti¢cation of p125FAK and paxillin tyrosine phos-
phorylation. Values are the mean þ S.E.M. (n = 7) expressed as
the percentage of the maximal increase caused by 10 nM EGF
above control unstimulated values.
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gin, an agent that speci¢cally inhibits the endoplas-
mic reticulum Ca2-ATPase and thereby depletes
Ca2 from intracellular compartments [36], was ex-
amined. Depletion of calcium from intracellular
stores after treatment with 10 WM thapsigargin for
1 h in a calcium-free medium had no e¡ect on the
increase in p125FAK and paxillin tyrosine phospho-
rylation caused by EGF (Fig. 5B, lanes 3 and 4), and
did not modify basal tyrosine phosphorylation sig-
ni¢cantly in control cells in the absence of EGF (Fig.
5B, lanes 1 and 2) or EGF-stimulated EGFR tyro-
sine phosphorylation (Fig. 5B, lanes 3 and 4). Pre-
viously we have shown [36] that pretreatment with
thapsigargin in a calcium-containing medium stimu-
lates calcium in£ux. Stimulation of calcium in£ux by
thapsigargin increased the tyrosine phosphorylation
of p125FAK and paxillin by 2.7 þ 0.3-fold and
1.8 þ 0.3-fold, respectively, but did not stimulate
EGFR tyrosine phosphorylation (Fig. 5C, lanes 1
and 2). Simultaneous stimulation of calcium in£ux
by thapsigargin and addition of EGF increased tyro-
sine phosphorylation of p125FAK and paxillin by
3.7 þ 0.6-fold and 2.2 þ 0.4-fold, respectively, over
control untreated cells. Therefore, the increase with
both thapsigargin and EGF together was no di¡erent
than the sum of the values obtained with each alone
(Fig. 5C, lane 4). Stimulation of calcium in£ux by
thapsigargin in a calcium-containing medium did not
modify EGF-stimulated EGF receptor tyrosine phos-
phorylation (Fig. 5C, lanes 2 and 4).
After EGF binds to the EGFR, in some cells it
causes activation of PI3-kinase [32,33]. To determine
whether PI3-kinase activation might be involved in
mediating the EGF stimulation of p125FAK and pax-
illin tyrosine phosphorylation in pancreatic acini, we
examined the e¡ect of a two unrelated PI3-kinase
inhibitors, wortmannin and LY294002 [19]. Pancre-
atic acini were pretreated for 30 min with di¡erent
concentrations of wortmannin and then incubated
with EGF (10 nM) (Figs. 6 and 7). Pretreatment
with wortmannin inhibited EGF-stimulated
p125FAK and paxillin tyrosine phosphorylation in a
concentration-dependent manner (Fig. 6) with a half-
maximal inhibition occurring with 100 nM wortman-
nin, and with almost complete inhibition achieved at
1 WM (Figs. 6 and 7). Pretreatment with a maximal
dose of wortmannin (i.e., 1 WM) did not modify basal
tyrosine phosphorylation signi¢cantly in control cells
in absence of EGF (Fig. 7) or alter the stimulation of
tyrosine phosphorylation of the EGF receptor in
EGF-treated cells (Fig. 7). Moreover, pretreatment
of pancreatic acini with 100 WM LY294002 for 1 h
Fig. 5. E¡ect of the selective PKC inhibitor, GF109203X, and
the tumor promoter, thapsigargin, in a calcium-free or -contain-
ing medium, on EGF stimulation of p125FAK and paxillin tyro-
sine phosphorylation in rat pancreatic acini. p125FAK and paxil-
lin tyrosine phosphorylation was determined as described in
Fig. 3. The p175 phosphotyrosine-containing band was deter-
mined as described in Fig. 1. (A) Pancreatic acini were pre-
treated for 2 h either in the absence or presence of 5 WM
GF109203X. Control cells received an equivalent volume of sol-
vent. Acini were then incubated for further 2.5 min with no ad-
ditions or with 10 nM EGF. Results are from a typical experi-
ment representative of three others in duplicate. (B) Pancreatic
acini were pretreated for 1 h either in the absence or presence
of 10 WM thapsigargin in a calcium-free medium (with EGTA
5 mM). Acini were then incubated for a further 2.5 min with no
additions or with 10 nM EGF. Results are from a typical ex-
periment representative of three others in duplicate. (C) Pancre-
atic acini were pretreated for 1 h either in the absence or pres-
ence of 10 WM thapsigargin in a calcium-containing-medium.
Acini were then incubated for a further 2.5 min with no addi-
tions or with 10 nM EGF. Results are from a typical experi-
ment representative of three others in duplicate.
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caused a 49 þ 12% and 47 þ 14% decrease in the ty-
rosine phosphorylation of p125FAK and paxillin by
EGF (10 nM) (Fig. 8), respectively. LY294002 pre-
treatment of control cells in the absence of EGF did
not modify basal tyrosine phosphorylation signi¢-
cantly in pancreatic acini (Fig. 8) or EGFR tyrosine
phosphorylation in EGF-treated cells (data not
shown).
In a previous study [27], we demonstrated that the
ability of CCK to cause tyrosine phosphorylation of
p125FAK and paxillin in rat pancreatic acini is crit-
ically dependent on the activation of the small GTP-
binding protein, p21rho. To determine whether p21rho
could be involved in the ability of EGF to stimulate
tyrosine phosphorylation of p125FAK and paxillin in
pancreatic acini, we examined the e¡ect of pretreat-
ment for 3 h with the exoenzyme, Clostridium botu-
linum C3 transferase, because the C3 transferase has
been shown to ADP-ribosylate p21rho which results
in its inactivation [37]. Pretreatment with C3 trans-
ferase decreased EGF-stimulated p125FAK and pax-
illin tyrosine phosphorylation by 77 þ 13% and
Fig. 6. Dose^inhibition curve of wortmannin on EGF stimula-
tion of p125FAK tyrosine phosphorylation in rat pancreatic aci-
ni. Pancreatic acini were pretreated for 30 min at 37‡C either in
the absence or presence of indicated concentrations of wort-
mannin. Acini were then incubated for a further 2.5 min with
no additions or with 10 nM EGF and then lysed. p125FAK and
paxillin tyrosine phosphorylation was determined as described
in Fig. 3. The top panel shows results from a typical experi-
ment representative of ¢ve others in duplicate. The bottom pan-
el show the quanti¢cation of p125FAK tyrosine phosphorylation.
Values are mean þ S.E.M. (n = 6) expressed as the percentage of
the maximal increase caused by 10 nM EGF above control un-
stimulated values. Signi¢cant di¡erences as compared to 10 nM
EGF: *P6 0.05, **P6 0.01, unpaired Student’s t-test.
Fig. 7. E¡ect of wortmannin on EGF stimulation of p125FAK,
paxillin and EGF receptor tyrosine phosphorylation in rat pan-
creatic acini. Pancreatic acini were pretreated for 30 min at
37‡C either in the absence or presence of 1 WM wortmannin.
Acini were then incubated for a further 2.5 min with no addi-
tions or with 10 nM EGF and then lysed. p125FAK and paxillin
tyrosine phosphorylation was determined as described in Fig. 3.
Tyrosine phosphorylation of EGF receptor (p175 phosphotyro-
sine-containing band) was analyzed by immunoprecipitation us-
ing PY20 and Western blotting with PY20 as described in Fig.
1. The top panel shows results from a typical experiment repre-
sentative of ¢ve others in duplicate. The bottom panel show the
quanti¢cation of p125FAK, paxillin and EGF receptor (p175) ty-
rosine phosphorylation. Values are mean þ S.E.M. (n = 6) ex-
pressed as the percentage of the maximal increase caused by
10 nM EGF above control unstimulated values.
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78 þ 35%, respectively (Fig. 9, top panel lanes 3,4 and
bottom panel). C3 transferase pretreatment of con-
trol cells in the absence of EGF did not modify basal
tyrosine phosphorylation signi¢cantly (Fig. 9, top
panel lanes 1 and 2). In addition, the EGF stimula-
tion of tyrosine phosphorylation of the EGF recep-
tor was not modi¢ed after C3 transferase pretreat-
ment (Fig. 9, top panel lanes 3,4 and bottom panel).
A number of neuropeptides and growth factors
[8,11,13,26,27] require the integrity of the actin cy-
toskeleton to cause p125FAK and paxillin tyrosine
phosphorylation. To determine whether the integrity
of the actin cytoskeleton might be necessary for the
ability of EGF to stimulate tyrosine phosphorylation
of p125FAK and paxillin, pancreatic acini were pre-
treated for 2 h with 3 WM cytochalasin D, a selective
disrupter of the actin ¢lament network [38]. Pretreat-
ment with cytochalasin D completely inhibited EGF-
stimulated p125FAK and paxillin tyrosine phospho-
rylation (Fig. 10, top panel lanes 3,4 and bottom
panel). However, actin cytoskeleton disruption after
cytochalasin D pretreatment did not modify the
stimulation of tyrosine phosphorylation of the EGF
receptor (Fig. 10, top panel lanes 3,4 and bottom
panel).
Fig. 8. E¡ect of LY 294002 on EGF stimulation of p125FAK ty-
rosine phosphorylation in rat pancreatic acini. Pancreatic acini
were pretreated for 1 h at 37‡C either in the absence or pres-
ence of 100 WM LY 294002. Acini were then incubated for a
further 2.5 min with no additions or with 10 nM EGF and
then lysed. p125FAK and paxillin tyrosine phosphorylation was
determined as described in Fig. 3. The top panel shows results
from a typical experiment representative of ¢ve others in dupli-
cate. The bottom panel shows the quanti¢cation of p125FAK ty-
rosine phosphorylation. Values are mean þ S.E.M. (n = 6) ex-
pressed as the percentage of the maximal increase caused by
10 nM EGF above control unstimulated values. Signi¢cant dif-
ferences as compared to 10 nM EGF: **P6 0.01, unpaired
Student’s t-test.
Fig. 9. E¡ect of the Clostridium botulinum C3 transferase on
EGF stimulation of p125FAK, paxillin and EGF receptor tyro-
sine phosphorylation in rat pancreatic acini. Pancreatic acini
were pretreated for 2 h at 37‡C either in the absence or pres-
ence of 25 Wg/ml of C3 transferase. Acini were then incubated
for a further 2.5 min with no additions or with 10 nM EGF
and then lysed. p125FAK and paxillin tyrosine phosphorylation
was determined as described in Fig. 3. Tyrosine phosphoryla-
tion of EGF receptor (p175 phosphotyrosine-containing-band)
was analyzed by immunoprecipitation using PY20 and Western
blotting with PY20 as described in Fig. 1. The top panel shows
results from a typical experiment representative of ¢ve others in
duplicate. The bottom panel shows the quanti¢cation of
p125FAK, paxillin and EGF receptor (p175) tyrosine phospho-
rylation. Values are mean þ S.E.M. (n = 6) expressed as the per-
centage of the maximal increase caused by 10 nM EGF above
control unstimulated values.
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4. Discussion
From extensive studies in other tissues [32,33] it is
known that the key event following EGF stimulation
is autophosphorylation within the EGF receptor in-
tracellular domain, and this process promotes inter-
action of the receptor with di¡erent target proteins
that became tyrosine-phosphorylated by the EGF re-
ceptor intrinsic tyrosine kinase activity. Examples in-
clude phospholipase CQ (PLCQ), the 85 kDa subunit
of PI3-kinase, GTPase-activating protein (GAP) and
members of the non-receptor Src family of tyrosine
kinases [32,33]. In pancreatic acini as in other tissues,
it is known that activation of the EGF receptor re-
sults in alteration in phospholipase C activity [21^23]
which results in changes in cytosolic calcium and
phosphoinositide levels [21^24], as well as changes
in cAMP levels [39] and phospholipase D activation
[40]. Recent studies suggest EGF in some tissues
[19,20] can cause tyrosine phosphorylation of
p125FAK and paxillin, which are known to be impor-
tant mediators of growth factors e¡ects in a number
of tissues [8^10]. It is unknown whether this is an
important transduction cascade for EGF in pancre-
atic acini, as has been recently shown for neuropep-
tides in these cells [17,27]. A number of results in the
present study show that tyrosine phosphorylation of
numerous proteins, of which p125FAK and paxillin
are two, are likely important mediators of EGF’s
action in pancreatic acini. First, EGF receptor acti-
vation in rat pancreatic acini caused a rapid increase
in the tyrosine phosphorylation of at least ¢ve phos-
photyrosine-containing bands of molecular masses
s 60 kDa. The identity of three of these proteins
was established in the present study. We provide evi-
dence that one of these phosphotyrosine-containing
bands is the EGF receptor, a second is the cytosolic
kinase, p125FAK, and a third band is the cytoskeletal
docking protein, paxillin. Second, the conclusion that
the 175 kDa phosphotyrosine-containing band is the
EGF receptor is supported by the ¢nding that this
protein interacts with a speci¢c EGF receptor anti-
body. Furthermore, anti-phosphotyrosine immuno-
precipitates prepared from EGF-treated pancreatic
acini lysates, from which the EGF receptor had
been removed by immunoprecipitation with the spe-
ci¢c anti-human EGF receptor antibody, showed no
increased in phosphotyrosine immunoreactivity in
the phosphotyrosine-containing band, p175. Third,
the conclusion that two of the increased phosphoty-
rosine-containing bands seen with EGF receptor ac-
tivation in rat pancreatic acini were due to tyrosine
phosphorylation of p125FAK and paxillin is sup-
ported by the identi¢cation of these two bands with
speci¢c antibodies for each of these proteins. The
fact that the tyrosine phosphorylation of p125FAK
and paxillin resulted from speci¢c EGF receptor in-
teraction was supported by the fact that EGF in-
duced a rapid increase in the tyrosine phosphoryla-
tion of the p125FAK and paxillin, and the time course
for tyrosine phosphorylation of both proteins corre-
Fig. 10. E¡ect of cytochalasin D on EGF stimulation of
p125FAK, paxillin and EGF receptor tyrosine phosphorylation
in rat pancreatic acini. Pancreatic acini were pretreated for 2 h
at 37‡C either in the absence or presence of 3 WM cytochalasin
D. Acini were then incubated for a further 2.5 min with no ad-
ditions or with 10 nM EGF and then lysed. p125FAK and paxil-
lin tyrosine phosphorylation was determined as described in
Fig. 3. Tyrosine phosphorylation of EGF receptor (p175 phos-
photyrosine-containing band) was analyzed by immunoprecipi-
tation using PY20 and Western blotting with PY20 as described
in Fig. 1. The top panel shows results from a typical experi-
ment representative of ¢ve others in duplicate. The bottom pan-
el shows the quanti¢cation of p125FAK, paxillin and EGF
receptor (p175) tyrosine phosphorylation. Values are mean þ
S.E.M. (n = 6) expressed as the percentage of the maximal
increase caused by 10 nM EGF above control unstimulated
values.
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late with the time course observed of the EGF re-
ceptor tyrosine phosphorylation. Furthermore, the
dose^response curve for tyrosine phosphorylation
of p125FAK and paxillin occurred over the same
EGF concentrations that EGF is reported to cause
mitogenic e¡ects [1,41], and the EGF concentration
required for a maximal responses in tyrosine phos-
phorylation of these two proteins is over the same
EGF concentrations that cause EGF receptor occu-
pation [42].
The ability of EGF receptor activation to stimu-
late tyrosine phosphorylation of p125FAK and paxil-
lin in rat pancreatic acini demonstrated both similar-
ities and di¡erences in kinetics and stoichiometry in
the ability of neuropeptides and other agents to stim-
ulate tyrosine phosphorylation of these two proteins
in rat pancreatic acini and other tissues. In the
present study, EGF-stimulated p125FAK and paxillin
tyrosine phosphorylation decreased sharply after 2.5
min, such that at 5 min any increase over the unstim-
ulated control was barely detected. Recently, a sim-
ilar time course for CCK-8 stimulation of p125FAK
tyrosine phosphorylation in rat pancreatic acini was
reported [17]. However, the time course for CCK-
stimulated paxillin tyrosine phosphorylation showed
di¡erent kinetics from those seen with EGF, in that
with CCK there was a sustained increase for more
than 20 min [17]. Moreover, the rapid decrease in the
EGF-stimulated p125FAK and paxillin tyrosine phos-
phorylation contrasts with previous results showing a
sustained increased in p125FAK and paxillin tyrosine
phosphorylation after stimulation with di¡erent
growth factors in other cell systems [9,10]. The stoi-
chiometry of EGF-mediated tyrosine phosphoryla-
tion of p125FAK and paxillin di¡ered also from that
recently shown with the neuropeptide, CCK, in pan-
creatic acini [17]. The dose^response curves for EGF
stimulation of tyrosine phosphorylation of p125FAK
and paxillin were similar to the ability of EGF to
cause receptor occupation in rat pancreatic acini
[1], demonstrating that EGF-stimulated p125FAK
and paxillin tyrosine phosphorylation and receptor
activation are closely coupled stoichiometrically. In
contrast, the relationship between receptor occupa-
tion of CCKA receptors and tyrosine phosphoryla-
tion of both proteins in rat pancreatic cells [17] dif-
fers from that seen with EGF because with CCK
submaximal receptor activation results in maximal
changes in p125FAK and paxillin phosphorylation,
so there is a receptor spareness for this intracellular
process with CCK, but not EGF.
The absence in the p125FAK of both SH2 and SH3
domains that could permit its direct binding to the
activated EGF receptor intracellular domain and fur-
ther phosphorylation, suggest that the activation of
additional intermediates are needed in EGF stimula-
tion of p125FAK and paxillin tyrosine phosphoryla-
tion. In other cell systems, PLCQ is a major target
protein for the EGF receptor tyrosine kinase [34] and
its activation increases inositol-(1,4,5)trisphosphate
(IP3) and diacylglycerol production, causing mobili-
zation of calcium and activation of protein kinase C
[34]. In a previous study [27] it was demonstrated in
rat pancreatic acini that PKC activation or increases
in intracellular calcium can cause stimulation of the
p125FAK and paxillin tyrosine phosphorylation.
Therefore, the fact that EGF stimulates PLCQ activ-
ity raises the possibility that PKC activation or cal-
cium mobilization could be possible mediators of
EGF stimulation of p125FAK and paxillin tyrosine
phosphorylation in rat pancreatic acini. However,
previous ¢ndings in rat pancreatic acini provide con-
£icting conclusions about the possible ability of EGF
receptor activation to alter the PLCQ activity in these
cells [21^23,39]. In a number of studies [21^23], EGF
did not cause a measurable increase in inositol phos-
phates in pancreatic acini. Moreover, EGF inhibited
increases in IP3 caused by other secretagogues such
as CCK [22,23]. In one study [24] but not in another
[22], EGF was reported to stimulate increases in the
intracellular calcium concentration in pancreatic aci-
ni. Furthermore, we were not able to detect any sig-
ni¢cant increase in the intracellular calcium concen-
tration in rat pancreatic acini after EGF stimulation
(data not shown). In the present study we established
that increases in intracellular calcium concentration
are not essential for the ability of EGF to stimulate
p125FAK and paxillin tyrosine phosphorylation. This
was established by demonstrating that, after pretreat-
ment of pancreatic acini with thapsigargin in a cal-
cium-free medium to deplete the intracellular calcium
stores, EGF-stimulated p125FAK and paxillin tyro-
sine phosphorylation were una¡ected. These results
demonstrate that calcium release from the intracellu-
lar stores is not important in mediating tyrosine
phosphorylation of these two proteins by EGF. Fur-
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thermore, an increase in the calcium in£ux had no
e¡ect on EGF stimulation of the tyrosine phospho-
rylation of p125FAK and paxillin. This result demon-
strated that increases in cytosolic calcium from ex-
tracellular stores are also not important for
stimulation of p125FAK and paxillin tyrosine phos-
phorylation by EGF. Lastly, our results suggest
that it is unlikely that PKC activation by EGF is
involved in stimulating tyrosine phosphorylation of
p125FAK and paxillin. This conclusion is established
by demonstrating that pretreatment of pancreatic
acini with the PKC inhibitor GF109203X, at a con-
centration that has been shown previously to com-
pletely inhibit TPA stimulation of tyrosine phospho-
rylation of these two proteins [27], had no e¡ect on
p125FAK and paxillin tyrosine phosphorylation
stimulated by EGF. These results demonstrate that
EGF stimulation of tyrosine phosphorylation of
p125FAK and paxillin in rat pancreatic acini resemble
the ability of bombesin, gastrin-releasing peptide and
neuromedin [43], but not CCK, endothelin or angio-
tensin II [43] to stimulate tyrosine phosphorylation
of these two proteins in other tissues and the lack of
involvement of PLC activation in mediating this
process.
The ability of growth factors to stimulate PI3-ki-
nase activation has been well characterized in a num-
ber of non-pancreatic tissues [32,33], and PI3-kinase
has been proposed to be involved in the regulation of
cell migration and cytoskeletal function in response
to growth factor stimulation [44]. Furthermore, a
recent study [19] suggests that PI3-kinase is impli-
cated in the regulation of p125FAK and paxillin tyro-
sine phosphorylation in response to PDGF and EGF
in Swiss 3T3 cells. Our results are consistent with the
conclusion that activation of PI3-kinase is important
in the ability of EGF to cause tyrosine phosphoryla-
tion of p125FAK and paxillin in pancreatic acini. This
conclusion is supported by the fact that pretreatment
of pancreatic acini with two structurally unrelated
PI3-kinase activity inhibitors, wortmannin and
LY294002, caused a signi¢cant reduction in EGF-
stimulated p125FAK and paxillin tyrosine phospho-
rylation. Wortmannin and LY294002 did not have
a non-speci¢c e¡ect, because they have no e¡ect on
the ability of EGF to stimulate tyrosine phosphoryl-
ation of the EGF receptor.
Recent studies [27,28] demonstrate in rat pancre-
atic acini and a number of other tissues that the
small GTP-binding protein p21rho is important for
p125FAK and paxillin tyrosine phosphorylation
caused by a number of neuropeptides and growth
factors, such as PDGF [45,46]. To examine the role
of the small GTP-binding protein p21rho in EGF-
stimulated p125FAK and paxillin tyrosine phospho-
rylation, we used the Clostridium botulinum C3 trans-
ferase which speci¢cally inactivates p21rho [37]. Our
results support the conclusion that p21rho is impor-
tant for the ability of EGF to stimulate tyrosine
phosphorylation in pancreatic acini because C3
transferase pretreatment markedly inhibited EGF-
stimulated p125FAK and paxillin tyrosine phospho-
rylation. The fact that C3 transferase did not have a
non-speci¢c e¡ect is supported by two ¢ndings. Pre-
treatment with C3 transferase had no e¡ect on the
ability of EGF to stimulate the EGF receptor tyro-
sine phosphorylation. Furthermore, in a previous
study [27], it was demonstrated in rat pancreatic aci-
ni under identical conditions that pretreatment with
C3 transferase had no e¡ect in CCK-stimulated in-
creases in phospholipase C activation.
Focal adhesions form a link between the cell cy-
toskeleton and the extracellular matrix and from
these structures emanate the actin stress ¢bers [47].
A study in Swiss 3T3 cells [8] shows that tyrosine
phosphorylation of p125FAK and paxillin by the
growth factor PDGF requires the integrity of the
actin cytoskeleton. Moreover, a recent study [27]
demonstrated that in rat pancreatic acini the integ-
rity of the actin cytoskeleton was required for
p125FAK and paxillin tyrosine phosphorylation
caused by the neuropeptide CCK-8. In the present
study we found that cytochalasin D, which disrupts
the integrity of the actin cytoskeleton [38], com-
pletely inhibited EGF-stimulated p125FAK and pax-
illin tyrosine phosphorylation in pancreatic acini.
This e¡ect appeared speci¢c for these proteins be-
cause EGF-stimulated tyrosine phosphorylation of
the EGF receptor was una¡ected. Thus, in rat pan-
creatic acini the phosphorylation of p125FAK and
paxillin by EGF depends on the integrity of the actin
cytoskeleton.
In summary, we found that EGF causes a rapid,
concentration-dependent tyrosine phosphorylation of
p125FAK and paxillin in rat pancreatic acini that is
stoichiometrically closely coupled to receptor occu-
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pation. In contrast to the action of a number of
neuropeptides in other cell systems, EGF-induced
p125FAK and paxillin tyrosine phosphorylation oc-
curs through a PKC- and calcium-independent mech-
anism. Activation of PI3-kinase and the small GTP-
binding protein, p21rho, are involved in EGF-stimu-
lated phosphorylation because pretreatment with
wortmannin, LY294002 or with C3 transferase inhib-
ited EGF stimulation of p125FAK and paxillin tyro-
sine phosphorylation by more than 50%. The order
of transduction of these processes was not explored
in the present study. However, in some other studies,
the site of action of the small GTP-binding protein
p21rho has been proposed to be upstream of the site
of action of PI3-kinase [29] whereas in another study
[48] on other tissues, it was reported to be down-
stream of the site of action of the PI3-kinase. More-
over, previous studies on other tissues provide con-
£icting results about the association of the 85 kDa
subunit of PI3-kinase with the EGF receptor internal
domain, suggesting that EGF-stimulated PI3-kinase
activation could be due to a direct interaction, after
association of p85 with the EGF receptor and phos-
phorylation [33], or an indirect one through intra-
cellular adapter proteins or after stimulation of intra-
cellular messengers [49]. In future studies the
sequence order of these cellular events will need to
be explored in pancreatic acini. Finally, our results
identify p125FAK and paxillin as components of the
intracellular pathways stimulated after EGF receptor
activation in pancreatic acini. However, at present
the relation between EGF-stimulated p125FAK and
paxillin tyrosine phosphorylation and EGF-stimu-
lated pancreatic functions is unknown, and this could
be an important issue to be explored in future studies
[50].
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